Literature DB >> 19776014

Glucocorticoid-mediated inhibition of Lck modulates the pattern of T cell receptor-induced calcium signals by down-regulating inositol 1,4,5-trisphosphate receptors.

Michael W Harr1, Yiping Rong, Martin D Bootman, H Llewelyn Roderick, Clark W Distelhorst.   

Abstract

Glucocorticoids are potent immunosuppressive agents that block upstream signaling events required for T cell receptor (TCR) activation. However, the mechanism by which glucocorticoids inhibit downstream responses, such as inositol 1,4,5-trisphosphate (IP(3))-induced calcium signals, is not completely understood. Here we demonstrate that low concentrations of dexamethasone rapidly convert transient calcium elevations to oscillations after strong TCR stimulation. Dexamethasone converted the pattern of calcium signaling by inhibiting the Src family kinase Lck, which was shown to interact with and positively regulate Type I IP(3) receptor. In addition, low concentrations of dexamethasone were sufficient to inhibit calcium oscillations and interleukin-2 mRNA after weak TCR stimulation. Together, these findings indicate that by inhibiting Lck and subsequently down-regulating IP(3) receptors, glucocorticoids suppress immune responses by weakening the strength of the TCR signal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776014      PMCID: PMC2797257          DOI: 10.1074/jbc.M109.005579

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

Review 1.  Glucocorticoids in T cell development and function*.

Authors:  J D Ashwell; F W Lu; M S Vacchio
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Minireview: latest perspectives on antiinflammatory actions of glucocorticoids.

Authors:  Karolien De Bosscher; Guy Haegeman
Journal:  Mol Endocrinol       Date:  2008-12-18

Review 3.  Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by reversible phosphorylation and dephosphorylation.

Authors:  Veerle Vanderheyden; Benoit Devogelaere; Ludwig Missiaen; Humbert De Smedt; Geert Bultynck; Jan B Parys
Journal:  Biochim Biophys Acta       Date:  2008-12-16

4.  Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines.

Authors:  M W Olszowy; P L Leuchtmann; A Veillette; A S Shaw
Journal:  J Immunol       Date:  1995-11-01       Impact factor: 5.422

5.  Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types.

Authors:  R J Wojcikiewicz
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

6.  Dexamethasone-induced inositol 1,4,5-trisphosphate receptor elevation in murine lymphoma cells is not required for dexamethasone-mediated calcium elevation and apoptosis.

Authors:  Michael C Davis; Karen S McColl; Fei Zhong; Zhengqi Wang; Michael H Malone; Clark W Distelhorst
Journal:  J Biol Chem       Date:  2008-02-13       Impact factor: 5.157

7.  Glucocorticoid action on depolarization-dependent calcium influx in brain synaptosomes.

Authors:  P Y Sze; Z Iqbal
Journal:  Neuroendocrinology       Date:  1994-05       Impact factor: 4.914

8.  Regulation of the inositol 1,4,5-trisphosphate receptor by tyrosine phosphorylation.

Authors:  T Jayaraman; K Ondrias; E Ondriasová; A R Marks
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728

9.  Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.

Authors:  N Auphan; J A DiDonato; C Rosette; A Helmberg; M Karin
Journal:  Science       Date:  1995-10-13       Impact factor: 47.728

10.  Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells.

Authors:  I M Adcock; C R Brown; C M Gelder; H Shirasaki; M J Peters; P J Barnes
Journal:  Am J Physiol       Date:  1995-02
View more
  13 in total

Review 1.  Glucocorticoid receptor: implications for rheumatic diseases.

Authors:  T Kino; E Charmandari; G P Chrousos
Journal:  Clin Exp Rheumatol       Date:  2011-10-21       Impact factor: 4.473

2.  Glucocorticoids downregulate Fyn and inhibit IP(3)-mediated calcium signaling to promote autophagy in T lymphocytes.

Authors:  Michael W Harr; Karen S McColl; Fei Zhong; Jason K Molitoris; Clark W Distelhorst
Journal:  Autophagy       Date:  2010-10-02       Impact factor: 16.016

3.  Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia.

Authors:  M W Harr; P F Caimi; K S McColl; F Zhong; S N Patel; P M Barr; C W Distelhorst
Journal:  Cell Death Differ       Date:  2010-03-19       Impact factor: 15.828

Review 4.  Apoptosis and autophagy: decoding calcium signals that mediate life or death.

Authors:  Michael W Harr; Clark W Distelhorst
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-09-08       Impact factor: 10.005

5.  Type of PaperY192 within the SH2 Domain of Lck Regulates TCR Signaling Downstream of PLC-γ1 and Thymic Selection.

Authors:  Matthias Kästle; Camilla Merten; Roland Hartig; Carlos Plaza-Sirvent; Ingo Schmitz; Ursula Bommhardt; Burkhart Schraven; Luca Simeoni
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 6.  Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.

Authors:  Janet P Hapgood; Chanel Avenant; Johnson M Moliki
Journal:  Pharmacol Ther       Date:  2016-06-08       Impact factor: 12.310

Review 7.  Ion Channels and Transporters in Inflammation: Special Focus on TRP Channels and TRPC6.

Authors:  Giuseppe A Ramirez; Lavinia A Coletto; Clara Sciorati; Enrica P Bozzolo; Paolo Manunta; Patrizia Rovere-Querini; Angelo A Manfredi
Journal:  Cells       Date:  2018-07-04       Impact factor: 6.600

8.  The impact of DMARD and anti-TNF therapy on functional characterization of short-term T-cell activation in patients with rheumatoid arthritis--a follow-up study.

Authors:  Balázs Szalay; Aron Cseh; Gergő Mészáros; László Kovács; Attila Balog; Barna Vásárhelyi
Journal:  PLoS One       Date:  2014-08-06       Impact factor: 3.240

9.  Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies.

Authors:  Alistair M Cook; Alison M McDonnell; Richard A Lake; Anna K Nowak
Journal:  Oncoimmunology       Date:  2015-09-16       Impact factor: 8.110

10.  Autoimmune Diseases in Patients with Cushing's Syndrome after Resolution of Hypercortisolism: Case Reports and Literature Review.

Authors:  Luigi Petramala; Federica Olmati; Maria Gabriella Conforti; Antonio Concistré; Valeria Bisogni; Nikita Alfieri; Gino Iannucci; Giorgio de Toma; Claudio Letizia
Journal:  Int J Endocrinol       Date:  2018-12-18       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.